A metabolically stable second-generation SERCA2a SUMOylation enhancer improves cardiac function in heart failure. Lee A, Oh JG, Mitsuyama S, Wang H, et al. J Mol Cell Cardiol 2026;218:55-66.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lee A, Oh JG, Mitsuyama S, Wang H, et al. A metabolically stable second-generation SERCA2a SUMOylation enhancer improves cardiac function in heart failure. J Mol Cell Cardiol 2026;218:55-66.
PMID: 42486183